1. Targeting YAP/TAZ mechanosignaling to ameliorate stiffness-induced Schlemm’s canal cell pathobiology
   Haiyan Li et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
2. RhoA Activation Decreases Phagocytosis of Trabecular Meshwork Cells
   Tomokazu Fujimoto et al, 2021, Current Eye Research CrossRef
3. Role of TGF-β1/SMADs signalling pathway in resveratrol-induced reduction of extracellular matrix deposition by dexamethasone-treated human trabecular meshwork cells
   Amy Suzana Abu Bakar et al, 2024, The Korean Journal of Physiology & Pharmacology CrossRef
4. RhoA/ROCK-YAP/TAZ Axis Regulates the Fibrotic Activity in Dexamethasone-Treated Human Trabecular Meshwork Cells
   Zhicheng Liu et al, 2021, Frontiers in Molecular Biosciences CrossRef
5. YAP/TAZ Promote Fibrotic Activity in Human Trabecular Meshwork Cells by Sensing Cytoskeleton Structure Alternation
   Shan Huang et al, 2022, Chemosensors CrossRef
6. Simvastatin Attenuates Glucocorticoid-Induced Human Trabecular Meshwork Cell Dysfunction via YAP/TAZ Inactivation
   Hannah Yoo et al, 2023, Current Eye Research CrossRef
7. The Hippo signalling pathway and its impact on eye diseases
   Yuxiang Du, 2024, Journal of Cellular and Molecular Medicine CrossRef
8. Glucocorticoids Preferentially Influence Expression of Nucleoskeletal Actin Network and Cell Adhesive Proteins in Human Trabecular Meshwork Cells
   William Bachman et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Extracellular Matrix Stiffness and TGFβ2 Regulate YAP/TAZ Activity in Human Trabecular Meshwork Cells
   Haiyan Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef